Table 2.
Distribution of RANK (rs8086340, C > G; rs1805034, C > T) and RANKL (rs7325635, G > A; rs7988338 G > A) genotypes in RA patients and controls
| Gene | Genotype | RA patients N (%) | Controls N (%) |
|---|---|---|---|
|
RANK rs8086340 |
CC | 37 (11.7%)a | 31 (19.0%) |
| CG | 155 (48.9%)b | 63 (38.7%) | |
| GG | 125 (39.4%) | 69 (42.3%) | |
|
RANK rs1805034 |
CC | 65 (20.4%) | 37 (22.7%) |
| CT | 153 (48.1%) | 80 (49.1%) | |
| TT | 100 (31.5%) | 46 (28.2%) | |
|
RANKL rs7325635 |
GG | 98 (30.8%) | 44 (27.2%) |
| GA | 147 (46.2%) | 87 (53.7%) | |
| AA | 73 (23.0%) | 31 (19.1%) | |
|
RANKL rs7988338 |
GG | 219 (68.9%) | 107 (65.6%) |
| GA | 91 (28.6%) | 50 (30.7%) | |
| AA | 8 (2.52%) | 6 (3.63%) |
N number of individuals with a given genotype
aOR = 1.777, 95% CI (1.069–3.010), p = 0.038
bOR = 1.519, 95% CI (1.039–2.227), p = 0.034